NEU neuren pharmaceuticals limited

Ann: Trofinetide marketing application submitted in Europe, page-17

  1. 992 Posts.
    lightbulb Created with Sketch. 453
    This announcement would’ve somewhat been priced in as it’s a known event, the only thing not known would’ve been the timing of the announcement. Which then again wouldn’t have that much of an impact on the SP.

    What wouldn’t of been known would’ve been the language used by the Acadia CEO indicating that they need to “return” Daybue to growth which would lead one to believe sales aren’t where they would want them to be.

    Still keeping an eye on this one as taking a position based on future development of 2591 interests me.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.